European Journal of Chemistry

Stability indicating HPLC-Fluorescence detection method for the simultaneous determination of linagliptin and empagliflozin in their combined pharmaceutical preparation

Crossmark


Main Article Content

Mohamed Rizk
Ali Kamal Attia
Heba Yosry Mohamed
Mona Elshahed

Abstract

A sensitive, accurate, and precise liquid chromatographic method has been developed and validated for the determination of Linagliptin (LNG) and Empagliflozin (EMP) in their combined tablets. Chromatographic separation was carried out on ODS-3 Inertsil® C18 column (150×4.6 mm, 5 µm). The mobile phase A (consisting of 0.30% Triethyl amine buffer (TEA) at pH = 4.5, adjusted using ortho-phosphoric acid); the mobile phase B (consisting of acetonitrile) was pumped through the column whose temperature was maintained at 40 °C, with a flow rate 1.7 mL/min, using gradient elution from 0-3 min A:B (75:25, v:v), then from 3-6 min the ratio changed to be A:B (60:40, v:v). Fluorescence detection (FLD) was performed at 410 nm after excitation at 239 nm. Acceptable linearity, accuracy and precision values of the proposed method were found over the concentration ranges of 0.5-15 µg/mL for LNG and 1.0-30 µg/mL for EMP with correlation coefficients of 0.9997 and 0.9998 in the case of LNG and EMP, respectively. The recoveries and relative standard deviations percentages were found in the following ranges: 98.56-101.85 and 0.53-1.52% for LNG and 98.00-101.95 and 0.31-1.05% for EMP. The detection and quantification limits were 0.15 and 0.45 µg/mL for LNG and 0.22 and 0.67 µg/mL for EMP. The optimized method was validated and proved to be specific, robust, accurate and reliable for the determination of the drugs in pure form or in their combined pharmaceutical preparations. No significant difference was found regarding accuracy and precision upon statistical comparison between the obtained results of the proposed method and those of the reported method. Furthermore, the proposed method is proved to be a stability-indicating assay after exposure of the studied drugs to variable forced degradation parameters, such as acidic, alkaline and oxidative conditions, according to the recommendations of the International Conference on Harmonization guidelines. The simplicity and selectivity of the proposed method allows its use in quality control laboratories.


icon graph This Abstract was viewed 1668 times | icon graph Article PDF downloaded 595 times

How to Cite
(1)
Rizk, M.; Attia, A. K.; Mohamed, H. Y.; Elshahed, M. Stability Indicating HPLC-Fluorescence Detection Method for the Simultaneous Determination of Linagliptin and Empagliflozin in Their Combined Pharmaceutical Preparation. Eur. J. Chem. 2021, 12, 168-178.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Madhusudhan, P.; Radhakrishna, M.; Devanna, N. Int. Adv. Res. J. Sci. Eng. Technol. 2015, 2, 95-99.

[2]. Jadhav, S.; Reddy, P.; Narayanan, K.; Bhosale, P. Sci. Pharm. 2017, 85, 25.
https://doi.org/10.3390/scipharm85030025

[3]. Godasu, S. K.; Sreenivas, S.A. Int. J. Pharm. Sci. Res. 2017, 8, 2223-2232.

[4]. Ayoub, B. M. RSC Adv. 2015, 5, 95703-95709.
https://doi.org/10.1039/C5RA17231D

[5]. Naazneen, S.; Sridevi, A. Der Pharm. Lett. 2016, 8, 57-65.

[6]. Jyothirmai, N.; Begum, K. M. D.; Supriya, P. J. Atoms Mol. 2016, 6, 977-986.

[7]. Jayalaxmi Rajesh, Dr. T.; Kumar, Dr. G.V. Int. J. Chem. Pharm. Sci. 2016, 4, 634-640.

[8]. Abdel-Ghany, M. F.; Abdel-Aziz, O.; Ayad, M. F.; Tadros, M. M. Acta Chromatogr. 2017, 29, 448-452.
https://doi.org/10.1556/1326.2016.00089

[9]. Srinivasa, R. M.; Anusha, K.; Muneer, S. J. Synth. Nat. Chem. 2017, 2, 1-6.

[10]. Sirigiri, N.; Subramanian, N.; Reddy, G. Saudi J. Med. Pharm. Sci. 2018, 4, 884-896.

[11]. Donepudi, S.; Achanta, S. Int. J. App. Pharm. 2018, 10, 56-61.
https://doi.org/10.22159/ijap.2018.v10s1.12

[12]. Jagadabi, V.; Nagendra Kumar, P. V.; Pamidi, S.; Ramaprasad, L. A.; Nagaraju, D. Int. Res. J. Pharm. 2018, 9, 192-201.
https://doi.org/10.7897/2230-8407.097148

[13]. Bakshi, A.; Mounika, A.; Bhutada, S.; Raju, Dr. M. B. World J. Pharm. Sci. 2018, 7, 1062-1071.

[14]. Lakshmana, R. A.; Prasanthi, T.; Anusha. E. L. IDMA 2019, 56, 68-71. http://www.indiandrugsonline.org/issuesarticle-details?id=OTM0 (accessed February 01, 2021).

[15]. Vankalapati, K. R.; Alegete, P.; Boodida, S. Biomed. Chromatogr. 2021, 35, e5019.
https://doi.org/10.1002/bmc.5019

[16]. Bhole, R. P.; Wankhede, S. B.; Pandey, M. Anal. Chem. Lett. 2017, 7, 76-85.
https://doi.org/10.1080/22297928.2017.1279567

[17]. Patel, I. M.; Chhalotiya, U. K.; Jani, H. D.; Kansara, D.; Shah, D. A. JPC - J. Planar Chromatogr. - Mod. TLC 2020, 33, 109-118.
https://doi.org/10.1007/s00764-020-00026-z

[18]. Padmaja, N.; Veerabhadram, G. Der Pharm. Lett. 2015, 7, 306-312.

[19]. Abdel-Ghany, M. F.; Abdel-Aziz, O.; Ayad, M. F.; Tadros, M. M. J. AOAC Int. 2017, 100, 1379-1391.
https://doi.org/10.5740/jaoacint.16-0314

[20]. Moussa, B. A.; Mahrouse, M. A.; Fawzy, M. G. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2018, 205, 235-242.
https://doi.org/10.1016/j.saa.2018.06.072

[21]. Amin, K. F.; Abdullah, A. M.; Fakhre, N. A. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2019, 222, 117261.
https://doi.org/10.1016/j.saa.2019.117261

[22]. Elmasry, M. S.; Hasan, M. A.; Hassan, W. S.; Merey, H. A.; Nour, I. M. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2021, 248, 119258.
https://doi.org/10.1016/j.saa.2020.119258

[23]. Rizk, M.; Attia, A. K.; Mohamed, H. Y.; Elshahed, M. S. Electroanalysis 2020, 32, 1737-1753.
https://doi.org/10.1002/elan.202000007

[24]. U. S. Food and Drug Administration, https://www.accessdata.fda.gov/ drugsatfda_docs/nda/2011/201280Orig1s000TOC.cfm (accessed February 01, 2021).

[25]. U. S. Food and Drug Administration, https://www.accessdata.fda.gov/ drugsatfda_docs/nda/2014/204629Orig1s000TOC.cfm (accessed February 01, 2021).

[26]. Abdel-Ghany, M. F.; Abdel-Aziz, O.; Ayad, M. F.; Tadros, M. M. Der Pharma Chem. 2016, 8, 186-189.

[27]. Shah, P. A.; Shrivastav, P. S.; George, A. Microchem. J. 2019, 145, 523-531.
https://doi.org/10.1016/j.microc.2018.11.015

[28]. ICH Guidelines, Stability testing of new drug substances and products Q1A (R2), International Conference on harmonization, Geneva, Switzerland, 2003; pp 1-24.

[29]. ICH Guidelines, In Validation of analytical procedures: text and methodology Q2 (R1), International conference on harmonization, Geneva, Switzerland, 2005; pp 11-12.

[30]. Miller, J. N.; Miller, J. C. Statistics and chemometrics for analytical chemistry, 5th Edition, Pearson Education Limited. Harlow, England. 2005.

[31]. United States Pharmacopeia, USP 39, National Formulary 34. (39th Ed.). Rockville, United States.: United States Pharmacopeial Convention INC. 2017.

Most read articles by the same author(s)

Most read articles by the same author(s)

TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).